IPC The Hospitalist Company - Value Alert
Texas (October 11, 2013) Wax Ink has issued a Negative Investment Interest opinion for IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) based on a recent baseline equity review that placed fair value between $34-$42.
Negative investment interest means that the current risk reward ratio does not favor investment consideration at this time.
The recent close of $49.45 is approximately 140% above the fair value buy target for the stock and approximately 17% above the fair value close target for the stock. The recent close is also 3% above analysts’ twelve-month $48.00 median price target for the stock.
The recent close represents an 11% increase in the one-year price of the stock, while year-over-year sales increased 14%, year-over-year earnings increased 16%, year-over-year debt increased 0%, and year-over-year free cash flow decreased 33%.
The stock currently has a trailing twelve-month PE Ratio of 23, and a PEG Ratio of 1.3 basis estimated forward earnings growth of 17.5%.
In the past 52 weeks, share prices have moved between a high of $55.49 and a low of $33.10, placing equilibrium at $49.44.
With the recent close, the stock is trading 12% below the 52 week high, 33% above the 52 week low, and 0% above equilibrium.
The three-month average daily trading volume for this stock is, approximately 83,000 shares.
IPC The Hospitalist Company is a provider of hospitalist services in the United States.
The company's listed competitors include Cogent HMG, EmCare Holdings,and Team Health Holdings.
Financial information contained herein, is based on the company's most recent annual SEC filing for year ending December 31, 2012 and all prices are per share unless otherwise noted.
Wax Ink currently has no investment position in any company mentioned in this alert.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D.
Copyright © 2013 Wax Ink Wax Ink is a baseline equity research company not licensed or registered with any government agency